Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination

Not Applicable

Not yet recruiting

• Conditions: Vaccination Hesitancy
• Interventions: Behavioral: Intensive MI; Behavioral: Standard MI; Behavioral: MOTIVACC; Behavioral: Ecological momentary assessment (EMA) messages

• Registration Number: NCT05977192
• Lead Sponsor: Oklahoma State University

Brief Summary

The objective of this study is to evaluate the preliminary efficacy and acceptability of an mobile Health-based motivational interviewing (MI) intervention to promote SARS-CoV-2 vaccination (MOTIVACC) compared to traditional phone-based MI.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-07-30
• Study First Submitted QC: 2023-08-02
• Study First Posted: 2023-08-04
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-29
• Study Start: 2024-04-01
• Last Update Posted: 2024-04-01
• Primary Completion: 2024-12-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• >18 years
• Reside in a rural area
• No previous dose of a SARS-CoV-2 vaccine
• Speak English
• Able to provide informed consent

Read More

Exclusion Criteria

• A cognitive or other disability that inhibits smart phone use
• Inability to participate because of medical or psychiatric conditions diagnosed by a physician/clinician
• Enrollment in other COVID-19 research; pregnant or lactating

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Standard MI	Ecological momentary assessment (EMA) messages	-
MOTIVACC	Ecological momentary assessment (EMA) messages	-
Intensive MI	Intensive MI	-
Standard MI	Standard MI	-
Intensive MI	Ecological momentary assessment (EMA) messages	-
MOTIVACC	MOTIVACC	-

Primary Outcome Measures

Name	Time	Method
Changes in vaccine hesitancy and confidence	Baseline and follow-up (8 weeks)
Changes in intention to receive the vaccine	Baseline and follow-up (8 weeks)

Secondary Outcome Measures

Name	Time	Method
Number of participants who receive the COVID-19 vaccine	Follow-up (8 weeks)
Changes in self-efficacy	Baseline and follow-up (8 weeks)
Changes in expectations related to vaccines	Baseline and follow-up (8 weeks)
Changes in ambivalence	Baseline and follow-up (8 weeks)
Changes in value-behavior discrepancy	Baseline and follow-up (8 weeks)

Trial Locations

Locations (2)

University of Oklahoma; 🇺🇸 Oklahoma City, Oklahoma, United States

Oklahoma State University; 🇺🇸 Stillwater, Oklahoma, United States